Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.21
0.060.42%
At close: -
$14.21
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Pediatrix Medical Group Analyst Ratings and Price Targets | NYSE:MD | Benzinga
Pediatrix Medical Group Inc has a consensus price target of $19.29 based on the ratings of 12 analysts. The high is $30 issued by Credit Suisse on May 3, 2022. The low is $9 issued by Jefferies on March 6, 2024. The 3 most-recent analyst ratings were released by UBS, Truist Securities, and Truist Securities on February 21, 2025, February 21, 2025, and January 6, 2025, respectively. With an average price target of $17.17 between UBS, Truist Securities, and Truist Securities, there's an implied 20.81% upside for Pediatrix Medical Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Truist Securities
Macquarie
Mizuho
Jefferies
1calculated from analyst ratings
Analyst Ratings for Pediatrix Medical Group
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/21/2025 | Buy Now | 30.19% | UBS | A.J. Rice68% | $16.5 → $18.5 | Maintains | Neutral | Get Alert |
| 02/21/2025 | Buy Now | 26.67% | Truist Securities | David Macdonald67% | $15 → $18 | Maintains | Hold | Get Alert |
| 01/06/2025 | Buy Now | 5.56% | Truist Securities | David Macdonald67% | $16 → $15 | Maintains | Hold | Get Alert |
| 12/16/2024 | Buy Now | 26.67% | Macquarie | Tao Qiu46% | → $18 | Initiates | → Outperform | Get Alert |
| 11/19/2024 | Buy Now | 5.56% | Mizuho | Ann Hynes86% | $13 → $15 | Maintains | Neutral | Get Alert |
| 11/05/2024 | Buy Now | 16.12% | UBS | A.J. Rice68% | $10.5 → $16.5 | Maintains | Neutral | Get Alert |
| 11/05/2024 | Buy Now | 26.67% | Jefferies | Jack Slevin25% | $14 → $18 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | 5.56% | Deutsche Bank | Pito Chickering67% | $9 → $15 | Maintains | Hold | Get Alert |
| 11/04/2024 | Buy Now | 12.6% | Truist Securities | David Macdonald67% | $13 → $16 | Maintains | Hold | Get Alert |
| 11/04/2024 | Buy Now | 5.56% | Mizuho | Ann Hynes86% | $13 → $15 | Maintains | Neutral | Get Alert |
| 10/07/2024 | Buy Now | -8.52% | Truist Securities | David Macdonald67% | $10 → $13 | Maintains | Hold | Get Alert |
| 09/26/2024 | Buy Now | -1.48% | Jefferies | Jack Slevin25% | $8 → $14 | Upgrade | Hold → Buy | Get Alert |
| 08/15/2024 | Buy Now | -29.63% | Truist Securities | David Macdonald67% | $8 → $10 | Maintains | Hold | Get Alert |
| 08/09/2024 | Buy Now | -26.11% | UBS | A.J. Rice68% | $9 → $10.5 | Maintains | Neutral | Get Alert |
| 07/15/2024 | Buy Now | -43.7% | Truist Securities | David Macdonald67% | $10 → $8 | Maintains | Hold | Get Alert |
| 06/07/2024 | Buy Now | -43.7% | Deutsche Bank | Pito Chickering67% | $8 → $8 | Upgrade | Sell → Hold | Get Alert |
| 05/15/2024 | Buy Now | -29.63% | Truist Securities | David Macdonald67% | $10 → $10 | Maintains | Hold | Get Alert |
| 03/06/2024 | Buy Now | -36.66% | Jefferies | Brian Tanquilut45% | $10 → $9 | Maintains | Hold | Get Alert |
| 02/21/2024 | Buy Now | -36.66% | Mizuho | Ann Hynes86% | $10 → $9 | Maintains | Neutral | Get Alert |
| 02/21/2024 | Buy Now | -29.63% | Truist Securities | David Macdonald67% | $10.5 → $10 | Maintains | Hold | Get Alert |
| 11/30/2023 | Buy Now | -33.15% | UBS | A.J. Rice68% | → $9.5 | Initiates | → Neutral | Get Alert |
| 10/11/2023 | Buy Now | 5.56% | Truist Securities | David Macdonald67% | $16 → $15 | Maintains | Hold | Get Alert |
| 05/09/2023 | Buy Now | 5.56% | Truist Securities | David Macdonald67% | $17 → $15 | Maintains | Hold | Get Alert |
| 02/22/2023 | Buy Now | 61.86% | Credit Suisse | Jonathan Yon51% | $27 → $23 | Maintains | Outperform | Get Alert |
| 12/05/2022 | Buy Now | 90.01% | Credit Suisse | Jonathan Yon51% | $28 → $27 | Maintains | Outperform | Get Alert |
| 11/16/2022 | Buy Now | 19.63% | Mizuho | Ann Hynes86% | $21 → $17 | Maintains | Neutral | Get Alert |
| 11/04/2022 | Buy Now | 12.6% | SVB Leerink | Whit Mayo68% | $20 → $16 | Maintains | Market Perform | Get Alert |
| 08/11/2022 | Buy Now | 97.04% | Credit Suisse | A.J. Rice68% | $30 → $28 | Maintains | Outperform | Get Alert |
| 08/10/2022 | Buy Now | 61.86% | BMO Capital | Matt Borsch76% | $25 → $23 | Maintains | Market Perform | Get Alert |
| 05/12/2022 | Buy Now | 40.75% | SVB Leerink | Whit Mayo68% | $24 → $20 | Maintains | Market Perform | Get Alert |
| 05/03/2022 | Buy Now | 111.12% | Credit Suisse | Jonathan Yong64% | $31 → $30 | Maintains | Outperform | Get Alert |
| 05/02/2022 | Buy Now | 61.86% | Mizuho | Ann Hynes86% | $28 → $23 | Maintains | Neutral | Get Alert |
| 04/27/2022 | Buy Now | 68.9% | SVB Leerink | Whit Mayo68% | $27 → $24 | Maintains | Market Perform | Get Alert |
FAQ
What is the target price for Pediatrix Medical Group (MD) stock?
The latest price target for Pediatrix Medical Group (NYSE:MD) was reported by UBS on February 21, 2025. The analyst firm set a price target for $18.50 expecting MD to rise to within 12 months (a possible 30.19% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pediatrix Medical Group (MD)?
The latest analyst rating for Pediatrix Medical Group (NYSE:MD) was provided by UBS, and Pediatrix Medical Group maintained their neutral rating.
When was the last upgrade for Pediatrix Medical Group (MD)?
The last upgrade for Pediatrix Medical Group Inc happened on September 26, 2024 when Jefferies raised their price target to $14. Jefferies previously had a hold for Pediatrix Medical Group Inc.
When was the last downgrade for Pediatrix Medical Group (MD)?
There is no last downgrade for Pediatrix Medical Group.
When is the next analyst rating going to be posted or updated for Pediatrix Medical Group (MD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pediatrix Medical Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pediatrix Medical Group was filed on February 21, 2025 so you should expect the next rating to be made available sometime around February 21, 2026.
Is the Analyst Rating Pediatrix Medical Group (MD) correct?
While ratings are subjective and will change, the latest Pediatrix Medical Group (MD) rating was a maintained with a price target of $16.50 to $18.50. The current price Pediatrix Medical Group (MD) is trading at is $14.21, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.